104 related articles for article (PubMed ID: 22001085)
21. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
Charlton J; Kirschenheuter GP; Smith D
Biochemistry; 1997 Mar; 36(10):3018-26. PubMed ID: 9062133
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of an NDPK phosphocarrier domain peptide containing a novel triazolylalanine analogue of phosphohistidine using click chemistry.
Yang SH; Lee DJ; Brimble MA
Org Lett; 2011 Oct; 13(20):5604-7. PubMed ID: 21939187
[TBL] [Abstract][Full Text] [Related]
24. Tuning activity-based probe selectivity for serine proteases by on-resin 'click' construction of peptide diphenyl phosphonates.
Serim S; Mayer SV; Verhelst SH
Org Biomol Chem; 2013 Sep; 11(34):5714-21. PubMed ID: 23884325
[TBL] [Abstract][Full Text] [Related]
25. Easy access to phosphonothioates.
Renard PY; Schwebel H; Vayron P; Josien L; Valleix A; Mioskowski C
Chemistry; 2002 Jul; 8(13):2910-6. PubMed ID: 12489219
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and mechanism of action of novel thiocarbamate inhibitors of human leukocyte elastase.
Li-Pan ZS; Joshi HV; Digenis GA
J Enzyme Inhib; 2000; 15(1):63-77. PubMed ID: 10850955
[TBL] [Abstract][Full Text] [Related]
27. [Quaternary phosphonic salts as reversible cholinesterase inhibitors].
Brestkin AP; Brovko VS; Zhukovskiĭ IuG; Kolchanova NA; Rozengart EV
Dokl Akad Nauk SSSR; 1984; 277(3):735-7. PubMed ID: 6489118
[No Abstract] [Full Text] [Related]
28. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of a chimeric peptide derived from fasciculin that inhibits acetylcholinesterase.
Falkenstein RJ; Gornalusse GG; Peña C
J Pept Sci; 2004 Jun; 10(6):342-9. PubMed ID: 15214439
[TBL] [Abstract][Full Text] [Related]
30. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
[TBL] [Abstract][Full Text] [Related]
31. Facile synthesis of peptide-porphyrin conjugates: Towards artificial catalase.
Umezawa N; Matsumoto N; Iwama S; Kato N; Higuchi T
Bioorg Med Chem; 2010 Sep; 18(17):6340-50. PubMed ID: 20696585
[TBL] [Abstract][Full Text] [Related]
32. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
[TBL] [Abstract][Full Text] [Related]
33. Macrocyclic inhibitors for the serine protease plasmin.
Xue F; Seto CT
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):779-94. PubMed ID: 18825554
[TBL] [Abstract][Full Text] [Related]
34. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.
Andreani A; Burnelli S; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Rizzoli M; Varoli L; Roda A
Eur J Med Chem; 2008 Mar; 43(3):657-61. PubMed ID: 17624631
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
[TBL] [Abstract][Full Text] [Related]
36. The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.
Musilek K; Pavlikova R; Marek J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Dolezal M; Gunn-Moore F; Kuca K
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):245-53. PubMed ID: 21406034
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
38. Fluorinated phosphonates: synthesis and biomedical application.
Romanenko VD; Kukhar VP
Chem Rev; 2006 Sep; 106(9):3868-935. PubMed ID: 16967924
[No Abstract] [Full Text] [Related]
39. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
